BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 37298623)

  • 1. A Direct Comparison, and Prioritisation, of the Immunotherapeutic Targets Expressed by Adult and Paediatric Acute Myeloid Leukaemia Cells: A Systematic Review and Meta-Analysis.
    Morris VS; Ghazi H; Fletcher DM; Guinn BA
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.
    Ashfaq K; Yahaya I; Hyde C; Andronis L; Barton P; Bayliss S; Chen YF
    Health Technol Assess; 2010 Dec; 14(54):iii-iv, ix-xi, 1-141. PubMed ID: 21138675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia.
    Aung MMK; Mills ML; Bittencourt-Silvestre J; Keeshan K
    Mol Oncol; 2021 Sep; 15(9):2253-2272. PubMed ID: 33421304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of continuous hierarchical heterogeneity by single-cell surface antigen analysis in the prognosis evaluation of acute myeloid leukaemia.
    Shao N; Ren C; Hu T; Wang D; Zhu X; Li M; Cheng T; Zhang Y; Zhang XE
    BMC Bioinformatics; 2023 Nov; 24(1):450. PubMed ID: 38017410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia.
    Goswami M; Hourigan CS
    Curr Drug Targets; 2017; 18(3):296-303. PubMed ID: 25706110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group.
    Kinoshita A; Miyachi H; Matsushita H; Yabe M; Taki T; Watanabe T; Saito AM; Tomizawa D; Taga T; Takahashi H; Matsuo H; Kodama K; Ohki K; Hayashi Y; Tawa A; Horibe K; Adachi S
    Br J Haematol; 2014 Oct; 167(1):80-6. PubMed ID: 25039450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.
    Mao C; Fu XH; Yuan JQ; Yang ZY; Huang YF; Ye QL; Wu XY; Hu XF; Zhai ZM; Tang JL
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010248. PubMed ID: 26544114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia.
    Skelding KA; Barry DL; Theron DZ; Lincz LF
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Pearson AD; Rossig C; Mackall C; Shah NN; Baruchel A; Reaman G; Ricafort R; Heenen D; Bassan A; Berntgen M; Bird N; Bleickardt E; Bouchkouj N; Bross P; Brownstein C; Cohen SB; de Rojas T; Ehrlich L; Fox E; Gottschalk S; Hanssens L; Hawkins DS; Horak ID; Taylor DH; Johnson C; Karres D; Ligas F; Ludwinski D; Mamonkin M; Marshall L; Masouleh BK; Matloub Y; Maude S; McDonough J; Minard-Colin V; Norga K; Nysom K; Pappo A; Pearce L; Pieters R; Pule M; Quintás-Cardama A; Richardson N; Schüßler-Lenz M; Scobie N; Sersch MA; Smith MA; Sterba J; Tasian SK; Weigel B; Weiner SL; Zwaan CM; Lesa G; Vassal G
    Eur J Cancer; 2022 Jan; 160():112-133. PubMed ID: 34840026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and emerging therapies for acute myeloid leukemia.
    Robak T; Wierzbowska A
    Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL)).
    Küley-Bagheri Y; Kreuzer KA; Monsef I; Lübbert M; Skoetz N
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD011960. PubMed ID: 30080246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic overview of chemotherapy effects in acute myeloid leukaemia.
    Kimby E; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naturally selected CD7 CAR-T therapy without genetic editing demonstrates significant antitumour efficacy against relapsed and refractory acute myeloid leukaemia (R/R-AML).
    Lu Y; Liu Y; Wen S; Kuang N; Zhang X; Li J; Wang F
    J Transl Med; 2022 Dec; 20(1):600. PubMed ID: 36517851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia.
    Edlin R; Connock M; Tubeuf S; Round J; Fry-Smith A; Hyde C; Greenheld W
    Health Technol Assess; 2010 May; 14 Suppl 1():69-74. PubMed ID: 20507806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) Patients.
    Greiner J; Brown E; Bullinger L; Hills RK; Morris V; Döhner H; Mills KI; Guinn BA
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex Screening for Interacting Compounds in Paediatric Acute Myeloid Leukaemia.
    Cairns LV; Lappin KM; Mutch A; Ali A; Matchett KB; Mills KI
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing the immune system in acute myeloid leukaemia.
    Austin R; Smyth MJ; Lane SW
    Crit Rev Oncol Hematol; 2016 Jul; 103():62-77. PubMed ID: 27247119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.